Survival and prognostic factors of oligometastatic non-small cell lung carcinoma: A single center experience
Sign Up to like & getrecommendations! Published in 2017 at "European Respiratory Journal"
DOI: 10.1183/1393003.congress-2017.pa4290
Abstract: Introduction: In patients without targeted-mutations platinum-based chemotherapy is still current treatment method with a median survival rates of 8-11 months. Patients with single side oligo-metastatic disease should be consider for curative aggressive therapies for both… read more here.
Keywords: survival prognostic; surgery months; months surgery; months crt ... See more keywords